Design Therapeutics Inc (DSGN) PT Lowered to $4 at RBC Capital

November 14, 2023 6:42 AM EST Send to a Friend
RBC Capital analyst Leonid Timashev lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login